If you’ve been watching T. Rowe Price Group lately, you’ve probably noticed the rebound—at around US$95.84 it’s had a pretty lively run. The stock is up 7.4% over the last 7 days and 8.2% over the last 30 days. Then you look further out: the 1-year return is 15.3%, but year to date it’s down 8.4%. So yeah, not exactly a straight line.
What makes the chatter stick, though, is the valuation angle. Misryoum newsroom reported that T. Rowe Price Group currently scores 5 out of 6 on a valuation check, and the company’s position in the current market cycle is getting a lot of investor attention. Established asset managers are still being weighed for their long-term, fee-based business models—while short-term market swings keep poking at confidence. It’s the kind of debate that can feel loud even when the numbers are calm.
Under the hood, Misryoum editorial desk noted that one valuation framework suggests the shares are materially below intrinsic value. The Excess Returns model starts with a Book Value of US$49.69 per share and a Stable EPS of US$9.05 per share, based on weighted future Return on Equity estimates from 4 analysts. It also uses a Cost of Equity of US$4.04 per share, implying an Excess Return of US$5.01 per share. The “spread” matters here—earnings used in the model sit above the required return, and that gap is basically doing the heavy lifting. The Average Return on Equity used is 17.38%, and the Stable Book Value input is US$52.06 per share, sourced from weighted future Book Value estimates from 2 analysts. Put together, the Excess Returns model points to an intrinsic value of about US$167.05 per share.
And when you compare that to the current share price—roughly US$95.84—the gap is big. That suggests the shares trade at a 42.6% discount, which screens as materially undervalued on this framework. Result: UNDERVALUED. There’s even a line that basically tells you to track it in a watchlist, or go hunt for more ideas like this—though, personally, I always pause at the cheerleading part. Market prices don’t care how nice a model feels, they care what investors will pay next.
Still, Misryoum editorial team stated that another approach points in the same direction, but with a different lens: price versus earnings. For T. Rowe Price Group, it currently trades on a P/E of 10.24x. The Capital Markets industry average is 40.14x, and the peer group average is 19.74x. Meanwhile, Misryoum newsroom reported a “Fair Ratio” of 12.56x—an estimate of what a reasonable P/E might be based on earnings profile, industry, profit margin, market value, and specific risks. With the current 10.24x below that 12.56x reference, the message is again that the shares may be undervalued on this earnings yardstick. Result: UNDERVALUED.
But valuation isn’t one story, and that’s where the narrative method gets interesting. Earlier, it was mentioned there’s an even better way to understand valuation—Misryoum analysis indicates the Narratives framework lets investors attach assumptions about revenue, earnings, and margins to produce a fair value you can compare with the current price. Each narrative is refreshed when new information comes in, so you’re not stuck staring at one static model.
For T. Rowe Price Group, the bull case narrative puts fair value at US$100.58 per share, implying a discount of about 4.7% based on the current price of US$95.84. It assumes revenue growth of 2.55% per year, revenue growth of 2.6% a year, and profit margins rising from 27.8% to 30.2% over the next 3 years. Analysts in that camp also expect earnings to reach about US$2.4b (US$11.20 per share) by around April 2029, with a P/E of 11.2x, below the 33.1x P/E quoted for the wider US Capital Markets industry. The consensus price target is US$100.58, roughly 10.4% above a current share price reference of US$90.14.
Then there’s the bear case narrative. Fair value there is US$83.00 per share, implying a premium of about 15.5% versus the current price of US$95.84. It assumes revenue growth of 1.73% per year and a more cautious path: revenue declines of 0.6% a year and profit margins easing from 28.8% to 28.2% over 3 years. Earnings are expected to stay around US$2.0b (US$9.01 per share) through 2028, valued on a 10.9x P/E using a 7.1% discount rate. Risks are laid out pretty plainly—fee pressure, net outflows, and execution risk on new products, with some offsets from ETFs, target date inflows, solid fund performance and capital returns.
You can probably feel the shape of it: the upside depends on expense discipline and product expansion; the downside depends on whether fee pressure and softer flows stick around longer than people want. I was looking at the spreadsheet portion of this in a coffee shop earlier—there was this faint hiss of steam from the espresso machine, and it made the whole thing feel a little more real, like the numbers were sitting somewhere you could almost touch. Still, your final call comes down to which narrative fits your expectations, and whether the recent rebound is the start of something—or just a pause. Misryoum cautions that this analysis is general in nature and not financial advice, and it may not factor in the latest price-sensitive company announcements or qualitative material.
Harvester at Meridian Park to close permanently April 24